Fertility, Pregnancy and Contraception — on Palbociclib

Based on animal studies and its mechanism of action, palbociclib is considered likely to cause harm to a developing fetus if taken during pregnancy. There is no direct human study on miscarriage risk, because it would not be ethical to conduct one — the requirement for contraception is based on what the drug is known to do to rapidly dividing cells and on findings from animal studies. If you become pregnant while taking palbociclib, tell your oncologist and your obstetrician as soon as possible.

Your oncologist or pharmacist can advise on which methods are considered effective for this purpose. Highly reliable methods — such as an intrauterine device, a contraceptive implant, or combined hormonal contraception — are generally preferred over methods that depend on consistent correct use, because an error is more consequential when a drug can harm a fetus. Some contraceptive methods can interact with hormone-based cancer treatments, so ask your team to confirm what is appropriate for you specifically rather than assuming any method is fine.

The contraception requirement applies to you — you should use effective contraception during treatment and for at least three months after your last dose. In practice, you and your partner will decide together which method to use. The important point is that the requirement extends three months beyond your last tablet, not just while treatment is ongoing. If your partner is already pregnant, tell your oncologist, because that needs prompt specialist input from both oncology and obstetrics.

Yes, and this is worth discussing before your first cycle rather than after treatment has begun. Egg freezing requires a stimulation cycle of around two weeks, which means a delay in starting — your oncologist will weigh whether that delay is safe for your specific situation. Sperm banking is simpler and faster. Raise fertility preservation at your first appointment so your team can arrange a referral to a reproductive specialist in time. Once certain other treatments — particularly chemotherapy — have started, some of these options may no longer be possible.

Tell your oncologist and your obstetrician as soon as possible. Do not stop palbociclib suddenly without medical advice, but continuing without a clinical review is equally not appropriate. Your team will need to assess where you are in treatment, the stage of the pregnancy, and what options exist — a conversation that needs specialist input from both sides. There is no single answer that fits every situation, and you deserve a calm, thorough discussion of the facts relevant to you.

Palbociclib is most often given alongside endocrine therapies such as letrozole or fulvestrant, and it is those accompanying treatments — rather than palbociclib itself — that most commonly affect periods and hormonal status. If you have noticed a change in your cycle or new menopausal symptoms, tell your oncologist so the cause can be identified. Do not assume that irregular or absent periods mean contraception is no longer needed: ovulation can still occur even when your cycle has changed, and the contraception requirement stands for the full treatment period and washout.